Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axis Stem Cell Institute is a private regenerative medicine and stem cell treatment provider operating clinics in Washington and Florida. The organization markets autologous regenerative procedures including adipose-derived stem cell therapy and platelet-rich plasma, and it also advertises peptide therapy, IV therapy, concierge care, and aesthetic or wellness-oriented services. Its clinical focus is broad and includes musculoskeletal, neurologic, autoimmune, metabolic, respiratory, and recovery-related conditions rather than a conventional drug-development pipeline. Based on available public materials, Axis appears to function as a cash-pay healthcare services business and specialty clinic rather than a biotech company developing FDA-tracked therapeutic assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axis Stem Cell Institute.